Partner Program · Version 1.0 · Effective September 15, 2026

Referral Partner Program Terms

These Terms govern your participation in the PX1 Research Referral Partner Program (the "Program"). By creating a partner account, clicking any acknowledgement, or otherwise participating in the Program, you agree to be bound by these Terms and all linked policies. Please read carefully — Section 13 contains an arbitration agreement and class-action waiver.

Research use only. All PX1 Research products are sold strictly for in-vitro laboratory research by qualified professionals. They are not for human or veterinary use, and partners may never promote them for any such use. See our Disclaimer.

1. Eligibility and Authority

You must be at least 21 years of age and legally able to enter into contracts in your jurisdiction. You represent and warrant that all information you provide is accurate and that you have full power and authority to enter into and perform under these Terms. You may not participate if PX1 Research has previously terminated your partner account, unless we expressly reinstate you in writing.

2. Independent Relationship — No Authority to Bind

You are an independent referrer, not an employee, agent, contractor, joint venturer, partner, or franchisee of PX1 Research or RTRC INVESTMENTS LLC. You have no authority to bind PX1 Research, accept payments on its behalf, negotiate on its behalf, make representations about PX1 Research, or hold yourself out as a representative, spokesperson, or official source of PX1 Research. You may not register domain names, social media handles, email addresses, or any other identifiers that could reasonably be confused with PX1 Research's own properties.

3. License to Use Brand Assets

Subject to these Terms, PX1 Research grants you a limited, revocable, non-exclusive, non-transferable, non-sublicensable license to share your referral link and to mention PX1 Research's product names in accurate, non-disparaging contexts. You may not modify our logos, marks, or trade dress, create derivative branding, or use any PX1 Research asset in a way that suggests endorsement, sponsorship, or official representation. This license terminates automatically upon any suspension or termination of your account, or at any time at PX1 Research's sole discretion upon notice.

4. Content Responsibilities and Restrictions

You are solely and personally responsible for the truth, legality, accuracy, and consequences of every statement, post, video, message, livestream, advertisement, or other communication you publish in connection with your referral activity. PX1 Research does not control, dictate, supervise, edit, or pre-approve your content and shall not be deemed a publisher, sponsor, or endorser of any of your content. You will not: • Describe PX1 Research products as suitable, safe, or intended for human use, human consumption, ingestion, injection, self-administration, dietary or supplement use, cosmetic use, veterinary use, or any medical or therapeutic application; • Provide dosing, administration, cycling, or usage instructions of any kind directed at humans or animals; • Claim or imply that any PX1 Research product treats, cures, mitigates, diagnoses, prevents, or alleviates any disease, illness, condition, symptom, or biological function; • Make any health, performance, hormonal, anti-aging, recovery, weight, fitness, or aesthetic claims; • Misrepresent discount amounts, fabricate discount percentages or limited-time offers, or otherwise mislead customers about pricing, savings, or program terms; • Make false, misleading, deceptive, exaggerated, or unsubstantiated claims about PX1 Research, its products, pricing, discounts, or business practices; • Use PX1 Research's name, trademarks, or marks in paid search campaigns, in domain names, or in any manner that would mislead consumers about the source of the offer; • Promote PX1 Research on platforms that prohibit such promotion or that primarily host content directed to minors; • Engage in negative SEO, brand bidding, cookie stuffing, self-referrals, fake clicks, or any practice designed to inflate or manipulate referral value.

5. Required Disclosures (FTC and Equivalent)

You must clearly and conspicuously disclose your material connection to PX1 Research in every piece of content where you include your referral code, your referral link, or any reference to PX1 Research's products. Acceptable disclosures include "#ad", "#affiliate", or plain-language statements such as "I earn a commission from this link." Disclosures must not be buried, abbreviated to ambiguous shorthand, or relegated to fine print. You are responsible for complying with the FTC Endorsement Guides (16 CFR Part 255) and any equivalent rules in every jurisdiction where your audience is located.

6. Lawful Conduct; Anti-Fraud

You will comply with all applicable federal, state, local, and international laws and regulations, including (without limitation) anti-spam laws (CAN-SPAM, CASL, GDPR, ePrivacy), consumer protection statutes, advertising disclosure rules, export controls, sanctions laws, and intellectual property rights. You will not engage in spam, unsolicited bulk messaging, scraping, account takeover, fraudulent clicks, cookie stuffing, self-referrals, identity misuse, AI-generated impersonation, deepfakes purporting to show PX1 Research personnel or products, or any other practice designed to deceive, inflate, or manipulate Program metrics.

7. Referral Value, Payouts, and Withholding Rights

Referral rates and the payout schedule are as posted on the Partner Program page and may be updated at any time at PX1 Research's sole discretion. Earned referral value is subject to chargebacks, returns, refunds, and fraud reviews. PX1 Research may withhold, delay, offset, claw back, forfeit, or refuse to pay any earned but unpaid referral value, in whole or in part, at its sole discretion, including (but not limited to) cases where PX1 Research has a good-faith belief that you have breached these Terms, manipulated the Program, engaged in fraud, generated suspicious activity, or where withholding is necessary to comply with law, tax obligations, court order, or third-party demand. Withheld referral value may be permanently forfeited. You waive any right to demand payment on a fixed schedule and acknowledge that PX1 Research's payment obligations are conditional on ongoing program compliance. Tax responsibility. You are solely responsible for all federal, state, local, and foreign taxes, duties, levies, withholdings, and similar charges arising from any referral value or other amount paid to you under the Program. PX1 Research has no obligation to advise you on tax matters, no obligation to gross-up or reimburse you for any tax liability, and no obligation to file or pay taxes on your behalf except as expressly required by law (for example, issuing IRS Form 1099-NEC or equivalent informational filings). You will keep your tax forms (W-9, W-8BEN, W-8BEN-E, or equivalent) accurate and current. Identity and tax verification. Before any payout can be released, you may be required to verify your identity and provide a completed, valid tax form (IRS Form W-9 for U.S. persons, or the applicable W-8 for non-U.S. persons). If you fail any portion of this processing — including inaccurate submitted information, identity verification failure, or incomplete or invalid tax forms — PX1 Research may hold unpaid referral value until the issue is resolved or, if not resolved within a reasonable time as determined by PX1 Research, may forfeit it.

8. Enforcement; At-Will Termination

You expressly acknowledge and agree that PX1 Research may, at its sole and absolute discretion, at any time, with or without cause, and with or without prior notice: • Terminate this agreement and your participation in the Program for any reason or no reason; • Suspend, restrict, modify, or close your partner account; • Deactivate your referral code, revoke your license to use PX1 Research's brand assets, and require removal of any content referencing PX1 Research; • Withhold, delay, offset, claw back, forfeit, or refuse to pay any earned but unpaid referral value, in whole or in part, with or without explanation; • Choose the type, severity, sequence, combination, and timing of any enforcement action, including warnings, payout holds, account suspension, or termination; • Interpret and apply these Terms in the manner PX1 Research determines is appropriate; • Decline to enter into or renew the Program relationship with any person, with or without reason. You waive any claim that PX1 Research must follow a specific process, sequence, standard of proof, or notice period before exercising any of the foregoing rights, except as required by applicable non-waivable law. No course of dealing, custom, or prior leniency by PX1 Research shall constitute a waiver of these rights. Termination by PX1 Research shall not give rise to any liability or damages of any kind, and you release PX1 Research from any such claim.

9. Audit, Investigation, and Cooperation

PX1 Research may, at any time and at its discretion, review, audit, monitor, archive, or investigate your content, communications, click sources, referred orders, payment behavior, identity, and tax information for compliance with these Terms or applicable law. You agree to cooperate in good faith with any such review, including providing records, taking down content within 24 hours of request, and responding to written inquiries. Failure to cooperate is itself a material breach and grounds for immediate suspension or termination.

10. Confidentiality

Non-public information you receive about the Program (including referral structures, payout volumes, conversion data, roadmaps, business plans, internal communications, and any beta features) is Confidential Information. You will not disclose Confidential Information to any third party or use it other than to perform under these Terms, both during and after your participation. This obligation survives termination indefinitely.

11. Indemnification

You agree to defend, indemnify, and hold harmless PX1 Research, RTRC INVESTMENTS LLC, and their affiliates, parents, subsidiaries, officers, directors, employees, agents, and contractors from and against all third-party claims, regulatory actions, damages, losses, liabilities, fines, costs, and expenses (including reasonable attorneys' fees and costs of defense) arising out of or relating to: (a) your content; (b) your acts or omissions; (c) your breach of these Terms or any representation, warranty, or covenant herein; (d) your violation of any law or third-party right (including IP, privacy, publicity, or contract rights); or (e) your relationship with any referred customer. PX1 Research may elect to assume the defense of any matter, in which case you will cooperate at your expense and will not settle any claim without PX1 Research's prior written consent.

12. Disclaimers; Limitation of Liability

The Program is provided "AS IS" and "AS AVAILABLE." PX1 Research disclaims all warranties, express, implied, statutory, or otherwise, including any warranties of merchantability, fitness for a particular purpose, non-infringement, accuracy, uptime, or that the Program will be uninterrupted, error-free, or profitable. To the maximum extent permitted by law, in no event shall PX1 Research be liable for any indirect, incidental, special, consequential, exemplary, or punitive damages, or for any loss of profits, revenues, data, business opportunities, or goodwill, whether arising from contract, tort (including negligence), strict liability, statute, or otherwise, even if PX1 Research has been advised of the possibility of such damages. PX1 Research's aggregate liability under or relating to these Terms is limited to the lesser of (a) the total referral value actually paid to you by PX1 Research in the six (6) months preceding the claim, or (b) one thousand U.S. dollars ($1,000).

13. Arbitration; Class-Action Waiver

READ THIS SECTION CAREFULLY — IT AFFECTS YOUR RIGHTS. Any dispute, claim, or controversy arising out of or relating to these Terms or the Program (a "Dispute"), other than a Dispute concerning intellectual property or injunctive relief, shall be resolved exclusively through final and binding individual arbitration administered by the American Arbitration Association ("AAA") under its Consumer Arbitration Rules, in Delaware or by video conference. The arbitrator's decision is final and judgment may be entered in any court of competent jurisdiction. You waive any right to participate in any class action, class-wide arbitration, private attorney general action, or other representative proceeding with respect to a Dispute. The arbitrator may not consolidate claims or preside over any form of class proceeding. If this class-action waiver is found unenforceable, the entirety of this Section 13 shall be null and void, and the Dispute shall be litigated in the state or federal courts located in Delaware, and you irrevocably consent to personal jurisdiction there. You may opt out of arbitration within 30 days of first accepting these Terms by sending written notice to info@px1research.com including your full name and account email.

14. Governing Law

These Terms are governed by the laws of the State of Delaware, without regard to its conflict-of-laws principles. The United Nations Convention on Contracts for the International Sale of Goods does not apply.

15. Future Modifications; Electronic Acceptance

PX1 Research may modify these Terms at any time. Modifications take effect upon posting an updated version with a new effective date. Your continued participation in the Program after the effective date of any update constitutes binding acceptance of the update. You consent to electronic records and signatures pursuant to the U.S. Electronic Signatures in Global and National Commerce Act (E-SIGN), the Uniform Electronic Transactions Act (UETA), and any equivalent local law. You agree that electronic acceptance of these Terms, including through the partner application form, constitutes a legally binding signature with the same force as a handwritten signature.

16. Survival; Severability; Waiver; Assignment

Survival. Sections 2, 4, 6, 7, 8–13, 15, and 16 survive any termination or expiration. Severability. If any provision of these Terms is held invalid or unenforceable, the remaining provisions remain in full force and effect. Waiver. No failure or delay by PX1 Research in exercising any right or remedy shall operate as a waiver. Assignment. PX1 Research may freely assign these Terms, in whole or in part, to any affiliate or successor in interest. You may not assign these Terms without PX1 Research's prior written consent; any prohibited assignment is void. Force Majeure. PX1 Research is not liable for any delay or failure to perform caused by events outside its reasonable control, including acts of God, war, terrorism, pandemic, civil unrest, labor disputes, internet outages, payment processor failures, or government action. No Third-Party Beneficiaries. These Terms do not confer any rights on any person other than the parties. Entire Agreement. These Terms (together with the on-file acknowledgements and any policies linked from here) constitute the entire agreement between you and PX1 Research regarding the Program and supersede all prior oral or written agreements, representations, or understandings.

17. Contact

Questions about these Terms or the Program: info@px1research.com. PX1 Research is owned and operated by RTRC INVESTMENTS LLC, doing business as PX1 Research.

— End of Partner Program Terms · Version 1.0 · Effective September 15, 2026 —